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Chemical Speciation Influences Comparative Activity of
Selenium-Enriched Garlic and Yeast in Mammary Cancer
Prevention
Clement Ip,*,† Marc Birringer,‡ Eric Block,‡ Miha´ly Kotrebai,§ Julian F. Tyson,§
Peter C. Uden,§ and Donald J. Lisk#
Department of Experimental Pathology, Roswell Park Cancer Institute, Buffalo, New York 14263;
Department of Chemistry, SUNYsAlbany, Albany, New York 12222; Department of Chemistry, University
of Massachusetts, Amherst, Massachusetts 01003; and Department of Fruit and Vegetable Science, Cornell
University, Ithaca, New York 14853
A recent human intervention trial showed that daily supplementation with selenized yeast (Se-
yeast) led to a decrease in the overall cancer morbidity and mortality by nearly 50%; past research
has also demonstrated that selenized garlic (Se-garlic) is very effective in mammary cancer
chemoprevention in the rat model. The goal of this study was to compare certain biological activities
of Se-garlic and Se-yeast and to elucidate the differences based on the chemical forms of selenium
found in these two natural products. Characterization of organic selenium compounds in yeast (1922
íg/g Se) and garlic (296 íg/g Se) was carried out by high-performance liquid chromatography with
inductively coupled plasma mass spectrometry or with electrospray mass spectrometry. Analytical
speciation studies showed that the bulk of the selenium in Se-garlic and Se-yeast is in the form of
ç-glutamyl-Se-methylselenocysteine (73%) and selenomethionine (85%), respectively. The above
methodology has the sensitivity and capability to account for >90% of total selenium. In the rat
feeding studies, supplementation of Se-garlic in the diet at different levels consistently caused a
lower total tissue selenium accumulation when compared to Se-yeast. On the other hand, Se-garlic
was significantly more effective in suppressing the development of premalignant lesions and the
formation of adenocarcinomas in the mammary gland of carcinogen-treated rats. Given the present
finding on the identity of selenomethionine and ç-glutamyl-Se-methylselenocysteine as the major
form of selenium in Se-yeast and Se-garlic, respectively, the metabolism of these two compounds is
discussed in an attempt to elucidate how their disposition in tissues might account for the differences
in cancer chemopreventive activity.
Keywords: Selenized natural product; garlic; yeast; chemical speciation of selenium; selenium cancer
prevention
INTRODUCTION
The most exciting news in selenium and cancer
prevention research in recent years is the finding by
Clark et al. (1996) that supplementation of free-living
people with selenized brewer’s yeast is capable of
decreasing the overall cancer morbidity and mortality
by nearly 50%. The study was a double-blind, random-
ized, placebo-controlled trial involving 1312 patients
(mostly men) who were recruited initially because of a
history of basal cell or squamous cell carcinoma of the
skin. Individuals in the treatment arm were given 200
íg of Se per day (average daily intake in the United
States is 100 íg) for a mean of 4.5 years. After a total
follow-up of 8271 person-years, selenium treatment did
not significantly affect the incidence of these nonmela-
noma skin lesions. However, patients receiving the Se-
yeast supplement showed a much lower prevalence of
developing and dying from lung, colon, or prostate
cancer (RR varied from 0.66 to 0.33). Although these
beneficial effects of selenium require independent con-
firmation with an appropriate design, the above study
demonstrated that selenium supplementation repre-
sents a safe and viable way of achieving significant
cancer protection.
The intervention trial of Clark et al. (1996) is a classic
example of “targeted chemoprevention” in which a
particular substance is given to high-risk individuals
for the purpose of reducing cancer morbidity. There is
a second concept of chemoprevention which is aimed at
providing cancer protective chemicals to large segments
of the population who are not at an increased risk
because of known exposure to carcinogens, genetic
predisposition, or prior diagnosis of malignancy (Wat-
tenberg, 1992). This plan requires a wide distribution
method, and an expeditious way of delivering these
protective agents is through foods.
It is almost impossible to increase selenium intake
by eating certain types of food because most common
foods have a very low selenium content (Morris and
Levander, 1970). Stimulated by the knowledge that
plants convert inorganic selenium in soil to organic
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selenium compounds following the sulfur assimilatory
pathway (Shrift, 1973), Ip and co-workers were able to
enrich garlic with selenium by fertilizing the crop with
water-soluble selenate and selenite salts (Ip et al., 1992).
By controlling the intensity and frequency of selenium
fertilization, it is possible to cultivate Se-garlic enriched
with 100-1355 íg/g Se dry weight (Ip and Lisk, 1995).
As a point of reference, natural garlic sold in the grocery
stores contains <0.05 íg/g Se. After harvest and pro-
cessing, the Se-garlic was lyophilized and milled to a
powder for feeding to laboratory animals for character-
ization of its cancer chemopreventive activity (Ip and
Lisk, 1994, 1995, 1997; Ip et al., 1996).
New methodologies of high-performance liquid chro-
matography with inductively coupled plasma mass
spectrometry (HPLC-ICP-MS) and with electrospray
mass spectrometry (ESI-MS) as well as gas chromatog-
raphy with atomic emission detection (GC-AED) have
recently been used to characterize a variety of organic
selenium compounds from natural sources at levels as
low as 20 ng/mL Se (Cai et al., 1995; Ge et al., 1996;
Bird et al., 1997a,b; Uden et al., 1998; Kotrebai et al.,
1999; Casiot et al., 1999). Our plan was to carry out
parallel analytical and biological studies on the same
batch of Se-garlic and Se-yeast so that the information
from selenium-enriched foods can be integrated and
interpreted in a meaningful manner.
MATERIALS AND METHODS
Se-Yeast and Se-Garlic. The high-selenium brewer’s yeast
was obtained from Nutrition 21, San Diego, CA. The material,
which was provided in a powder form (95% through 60 mesh),
contained 1922 íg/g Se on a dry weight basis. The Se-garlic,
produced by inorganic selenium salt fertilization as described
previously (Ip et al., 1992), contained 296 íg/g Se. Total
selenium analysis was determined by using the fluorometric
method of Olson et al. (1975) or by ICP-MS (Uden et al., 1998;
Kotrebai et al., 1999).
Instrumentation. An inductively coupled plasma mass
spectrometer (ICP-MS) (Elan 5000, Perkin-Elmer Sciex, Thorn-
hill, ON, Canada) served as the detector for HPLC. Samples
were introduced by a Meinhard nebulizer with a spray
chamber containing an impact bead. The ICP-MS parameters
were as described elsewhere (Kotrebai et al., 1999). The
chromatographic system consisted of a pump (SP8810, Spectra-
Physics, San Jose, CA) and a 5 ím Symmetry Shield RP8
column (3.9 mm  15 cm; Waters Corp., Milford, MA). The
column was connected to the nebulizer with PEEK tubing (30
cm  0.25 mm i.d.). The mobile phase composition was 99:1
(v/v) water/methanol with 0.1% trifluoroacetic acid or 0.1%
heptafluorobutanoic acid. The mobile phase flow rate was
typically 1.0 mL/min, and the sample injection volume was
20 íL.
A Bruker-Hewlett-Packard Esquire-LC mass spectrometer
(Bruker-Franzen Analytik GmbH, Bremen, Germany) was
used for the molecular mass spectral studies. For HPLC-MS
analysis, the 1 mL/min column output was split in a 1:5 ratio
with a T flow splitter. The column was connected to the ESI
source with PEEK tubing (8 cm  0.25 mm i.d.). Mass
calibration and optimization were performed daily.
Chemicals. Barnstead E-pure 18 Mohm water (Boston,
MA), hydrochloric acid (purified by sub-boiling), trifluoroacetic
acid (Aldrich, Milwaukee, WI), and methanol (HPLC grade)
were used. DL-Selenomethionine and Protease XIV were
obtained from Sigma (St. Louis, MO). Se-Adenosyl-DL-seleno-
homocysteine and ç-glutamyl-Se-methyl-L-selenocysteine were
synthesized in-house (E. Block et al., unpublished data). Stock
solutions of selenoamino acids were prepared in 0.2 M HCl.
All solutions were stored in the dark at 0-4 °C.
Sample Preparation. The enzymatic and hot water ex-
tractions of Se-garlic and Se-yeast followed the procedures
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briefly summarized here. For the hot water extraction, 5 mL 
of distilled deionized water was added to 0.2 g of sample in a 
15-mL centrifuge tube, and the tube was placed in a double-
boiling water bath for an hour. The mixture was shaken well 
every 15 min. For the enzymatic extraction, 5 mL of distilled 
deionized water was added to 0.2 g of sample and 0.02 g of 
Protease XIV enzyme in a 15-mL centrifuge tube and shaken 
for 24 h at room temperature. For the preparation of concen-
trated extracts, the original sample-to-water ratio (0.2 g/5 mL) 
was increased 5-fold. After the extraction, the samples were 
centrifuged and filtered.
Design of in Vivo Experiments in Rats. The biological 
activities of Se-yeast and Se-garlic were evaluated in rats with 
the use of three separate endpoints: tissue selenium ac-
cumulation, reduction of premalignant lesions in the mam-
mary gland, and mammary cancer prevention bioassay. Patho-
gen-free female Sprague-Dawley rats were purchased from 
Charles River Breeding Laboratories (Wilmington, NC) at 45 
days of age. They were fed the AIN-76A basal diet (Report of 
the American Institute of Nutrition, 1977) for several days to 
acclimatize them to the powder ration. This basal diet con-
tained 0.1 íg/g Se as sodium selenite. At 50 days of age, the 
animals were entered into different experimental protocols as 
described below.
For the tissue selenium accumulation study, rats were given 
either Se-garlic or Se-yeast, supplemented to the basal diet 
at a final concentration of 1, 2, or 3 íg/g Se (n ) 6/group). The 
feeding continued for 6 weeks, at which point the animals were 
sacrificed. Liver, kidney, mammary gland, skeletal muscle, and 
plasma were collected at necropsy. The samples were frozen 
immediately in liquid nitrogen and stored at -80 °C until 
ready for analysis of total selenium (Olson et al., 1975).
For the mammary gland premalignant lesion study, rats 
were injected i.p. with methylnitrosourea (MNU) at a dose of 
50 mg/kg of body weight. Immediately after carcinogen ad-
ministration, animals were divided into three groups (n ) 6 
rats/group): control (fed basal diet containing 0.1 íg/g Se), Se-
garlic (at 3 íg/g Se), and Se-yeast (at 3 íg/g Se). Animals were 
sacrificed at 6 weeks after selenium supplementation. The 
abdominal-inguinal mammary gland chain was excised in one 
piece, fixed in 10% buffered formalin, and processed in a 
Tissue-Tek vacuum infiltration processor. After processing, it 
was divided into six segments and embedded in paraffin 
blocks. Ribbons of 5-ím thickness were cut from each block 
and placed on slides that had been treated with 3-aminopro-
pyltriethoxysilane. Every 10th section was heat immobilized, 
deparaffinized in xylene, rehydrated in descending grades of 
ethanol, and stained with hematoxylin and eosin. These H&E 
slides were examined under the microscope for the appearance 
of premalignant intraductal proliferation (IDP) lesions using 
the criteria delineated by Russo et al. (1982). Once an IDP 
lesion was found, the in-between slides were similarly stained 
to confirm the histology. The size of each lesion could thus be 
estimated operationally by the number of serial sections 
showing the pathology. The total IDP count data were ana-
lyzed by the chi square test using the Poisson regression model 
(McCullagh and Nelder, 1989).
Two mammary cancer prevention bioassays were carried 
out, one with the MNU model and the other with the 
dimethylbenz[a]anthracene (DMBA) model. Rats in each 
experiment were given a dose of MNU (50 mg/kg of body wt) 
i.p. or DMBA (50 mg/kg of body wt) i.g. at 50 days of age for 
the induction of mammary tumors. They were then fed the Se-
garlic- or Se-yeast-containing diet at a level of 3 íg/g Se. 
Control rats continued to receive the basal diet containing 0.1 
íg/g Se. All animals were palpated for mammary gland tumors 
once a week. The experiment was continued for 24 weeks 
before termination. By this time, the development of palpable 
tumors had plateaued for several weeks across all groups. At 
necropsy, all tumors were excised and fixed for histological 
evaluation. Only confirmed adenocarcinomas are reported in 
the results. Tumor incidences at the final time point were 
compared by chi-square analysis, and the total tumor yield
was compared by frequency distribution analysis as described
previously (Horvath and Ip, 1983).
RESULTS
HPLC-ICP-MS Analysis. On-line HPLC-ICP-MS
chromatograms, using 0.1% trifluoroacetic acid as ion-
pairing agent, of enzymatic extract of Se-yeast and
water extract of Se-garlic are shown in parts a and b,
respectively, of Figure 1 (0.2 g/5 mL of sample extract).
The identities of the peaks eluting at 3.08 and 6.21 min
(Figure 1a) and at 4.95 min (Figure 1b) were first
established by spiking the samples with the appropriate
standards. The peaks were identified as selenomethion-
ine, Se-adenosylselenohomocysteine, and ç-glutamyl-Se-
methylselenocysteine, respectively. The peak at 11.45
min (Figure 1b) could not be matched by retention time
against any available standard.
Comparison of a yeast water extract (not shown) with
Figure 1a showed the absence of the major selenom-
ethionine peak, suggesting that it is immobilized, per-
haps in proteins; Se-adenosylselenohomocysteine ap-
peared as the major selenium compound. The extraction
efficiency and column recovery values of selenium for
the enzymatic extracts of yeast were 80-90%, whereas
the hot water extraction efficiency was only 10% (Uden
et al., 1998; Kotrebai et al., 1999). The two identified
compounds account for 82% of the total selenium in
compounds eluting from the enzymatic extract.
Figure 1. (A) HPLC-ICP-MS chromatogram, using 0.1% trifluoroacetic acid ion pairing agent, of the enzymatic extract of selenium-
enriched yeast containing 1922 íg/g total selenium; (B) HPLC-ICP-MS chromatograms, using 0.1% trifluoroacetic acid, of the hot
water extract (top) and the enzymatic extract (bottom) of selenium-enriched garlic containing 296 íg/g total selenium.
Comparison of the garlic powder’s water extract with
its enzymatic extract (Figure 1b) shows no major
difference in the ç-glutamyl-Se-methylselenocysteine
peak areas, indicating that it is not immobilized into
proteins. As observed in the case of yeast, selenom-
ethionine (peak at 3.1 min) was effectively extracted
only by the enzymatic process. For garlic powder, the
hot water extraction column recovery values were 80-
90%, ç-glutamyl-Se-methylselenocysteine accounting for
85% of the total selenium compounds eluted. With
enzymatic extraction, the efficiency approached 100%,
with selenomethionine and ç-glutamyl-Se-methylsele-
nocysteine together accounting for 86% of the total
selenium species eluted.
The separation achieved by the use of trifluoroacetic
acid (Figure 1a,b) was not of adequate resolution to
identify the early eluting peaks in the chromatogram.
To identify the compounds in that region, heptafluo-
robutanoic acid, a much stronger ion-pairing agent, was
used. This separation is demonstrated in Figure 2. The
identifications of (a) selenate, (b) selenite, (c) seleno-
lanthionine, (d) selenocystine, (e) selenocystathionine,
and (f) Se-methylselenocysteine were made by spiking
the samples with the appropriate standards. As noted
above, the extraction efficiency from yeast was esti-
mated to be between 80 and 90% based on total
selenium content, whereas that from garlic was close
to 100% on the same basis. The independence of ICP-
MS response for selenium-82 with respect to molecular
structure enables total chromatographic peak area
measurements to be used for these calculations with
confidence. The percentage composition of the selenium
content eluted from the column, taking into account the
foregoing extraction efficiency, is reported in Table 1.
HPLC-ESI-MS Analysis. All analyses were carried
out on-line, to preclude sample decomposition during
the preconcentration procedure. Figure 3 shows the
overlaid single ion chromatograms (SIC) of selenom-
ethionine (3.41 min), ç-glutamyl-Se-methylselenocys-
teine (5.07 min), and Se-adenosylselenohomocysteine
(6.39 min) at selenium concentrations of 50, 20, and 10
íg/mL, respectively. Separate chromatograms were run
to obtain the best combination of response and peak
shapes for the different levels of selenium in the three
components. The selenomethionine has a molecular ion
M + 1 at 198 with a loss of 17, which is attributed to
ammonia, producing a fragment ion at m/z 181. The M
+ 1 values for ç-glutamyl-Se-methylselenocysteine and
Se-adenosylselenohomocysteine are 313 and 433, re-
spectively. The distinctive selenium isotopic pattern
[74Se (1%), 76Se (9%), 77Se (8%), 78Se (24%), 80Se (50%),
82Se (9%)] is clearly seen in each case.
The SIC of m/z 313 (5.11 min) and m/z 327 (10.12 min)
from “dilute” (0.2 g/5 mL) and “concentrated” (1 g/5 mL)
hot water extracts of garlic, respectively, are shown in
Figure 4. The “concentrated” extracts showed a reten-
tion time decrease as seen for Figure 2 (11.45 min) and
Figure 4 (10.12 min) for the same compound, due to
Figure 2. HPLC-ICP-MS chromatograms of the hot water extract (top) and the enzymatic extract (bottom) of selenium-enriched
garlic containing 296 íg/g total selenium.
Table 1. Percent Composition of Identified Selenium
Species Based upon Selenium Content of Selenized
Garlic and Yeast
296 íg/g Se-
garlic (%)
1922 íg/g Se-
yeast (%)
(a) selenate 2
(b) selenite 1
(c) selenolanthionine 1.5
(d) selenocystine 0.5 0.5
(e) selenocystathionine 0.5 1
(f) Se-methylselenocysteine 3 0.5
(g) selenomethionine 13 85
(h) ç-glutamyl-Se-methylseleno-
cysteine
73 0.5
(i) Se-adenosyl selenohomocysteine 3
(j) ç-glutamyl-selenomethionine 4
percentage sum of eluted seleniuma 96 93
a Percentage sum is based on total eluted selenium by HPLC-
ICP-MS, calculated from peak area measured at 82Se.
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overloading of the column. The same effect was seen
when the injection volume of the dilute extract was
increased 5-fold from 20 to 100 íL. The mass spectrum
of the 5.11 min peak confirms the identification of this
peak as ç-glutamyl-Se-methylselenocysteine. The peak
at 10.12 min was tentatively identified as ç-glutamylse-
lenomethionine on the basis of its molecular weight, the
region where it elutes, and the fact that ç-glutamylme-
thionine occurs in garlic (Virtanen, 1965; Koch and
Lawson, 1996), but a standard to confirm its retention
time is not yet available.
The SIC of m/z 198 (3.14 min) and m/z 433 (6.31 min)
from the dilute enzymatic extract of Se-yeast appears
in Figure 5. A similar mass spectrum is obtained for
the peak eluting at 6.3 min from the hot water extract
of the same sample. The mass spectra of the peaks at
3.14 and 6.31 min confirm their identity as seleno-
methionine and Se-adenosylselenohomocysteine, respec-
Figure 3. HPLC-ESI-MS SIC of DL-selenomethionine (3.41 min, m/z 198), ç-glutamyl-Se-methylselenocysteine (5.07 min, m/z
313), and Se-adenosylselenohomocysteine (6.39 min, m/z 433) with concentrations of 50, 20, and 10 íg/mL selenium, respectively,
recorded in three separate injections and overlaid in one chromatogram.
Figure 4. HPLC-ESI-MS SIC chromatograms of m/z 313 (5.11 min) and 327 (10.12 min) ions with their spectra from the water
extract of selenium-enriched garlic containing 296 íg/g total selenium.
tively, reinforcing the off-line identification of Se-ad-
enosylselenohomocysteine in the water extract of Se-
yeast (Casiot et al., 1999). The additional noted ions
appearing in these spectra in comparison with the
HPLC of the reference compounds in Figure 3 are due
to non-selenium-containing species coeluting or overlap-
ping with the target analytes. These give rise to ESI-
MS spectra but are, of course, not seen in selenium
selective HPLC-ICP-MS.
Evaluation of Biological Activities. Table 2 shows
the data of total selenium accumulation in tissues of
rats fed either Se-garlic or Se-yeast. Both supplements
produced a dose-dependent elevation in selenium levels
in all tissues examined. However, in every case, Se-yeast
caused a significantly higher increase in total selenium
as compared to Se-garlic when either one was supple-
mented in the range of 1-3 íg/g dietary selenium. For
example, at the 3 íg/g Se dose, the concentrations of
selenium in liver, kidney, mammary gland, skeletal
muscle, and plasma were 54, 57, 51, 53, and 31% less,
respectively, in rats fed Se-garlic than in those fed Se-
yeast. Thus, it is clear that Se-garlic at chemopreventive
levels of intake results in only a modest change in tissue
selenium.
The pathobiology of chemical carcinogenesis in the rat
mammary gland has been well elucidated by the team
of Russo and Russo (1982). Their work provided evi-
dence that the terminal end buds are the primary sites
for the induction of mammary carcinomas. Within 2-3
weeks after carcinogen dosing, enlargement of the ter-
minal end bud, due to a localized piling up of intraductal
cells, is detectable in histological sections. These trans-
formed cells continue to proliferate until they gradually
fill up the lumen of the duct. These premalignant
“intraductal proliferations”, or IDPs, are the precursors
for the eventual development of palpable carcinomas.
The total count of these IDP lesions in the abdominal-
inguinal mammary gland chain was quantified as
described under Materials and Methods. The size of
each lesion was also determined operationally by the
number of serial sections showing the same pathology.
Table 3 shows the IDP lesion results from MNU-
treated rats that were fed either Se-garlic or Se-yeast.
The histology of the mammary gland sections was
evaluated at 6 weeks after carcinogen administration.
There were 40 IDPs found in a total of 6 rats in the
control group, 17 in the Se-garlic group, and 29 in the
Se-yeast group. These values are all significantly dif-
ferent from each other (refer to footnote of Table 3 for
statistical comparisons). The lesions were categorized
into four size classes with each containing e10, 11-20,
21-30, or 31-40 serial sections. To analyze the size
class data, a repeated-measures option was added to the
Poisson regression because most animals presented
lesions in more than one size class. No significant
differences were found by treatment within a size class,
Figure 5. HPLC-ESI-MS SIC chromatograms of m/z 198 (3.14 min) and 433 (6.31 min) ions with their spectra from the enzyme
extract of selenium-enriched yeast containing 1922 íg/g total selenium.
Table 2. Tissue Selenium Levels in Rats Fed Se-Garlic or Se-Yeast
selenium concn (íg/g or mL)
treatment
dietary selenium
(íg/g) liver kidney mammary muscle plasma
none 0.1 4.1 ( 0.22 5.1 ( 0.26 0.12 ( 0.01 0.8 ( 0.03 0.42 ( 0.02
Se-garlic 1 5.1 ( 0.38a 6.1 ( 0.41a 0.14 ( 0.01a 1.0 ( 0.02a 0.51 ( 0.03a
Se-garlic 2 6.1 ( 0.47b 7.6 ( 0.49b 0.19 ( 0.01b 1.5 ( 0.03b 0.56 ( 0.03b
Se-garlic 3 7.3 ( 0.60c 8.7 ( 0.66c 0.20 ( 0.02c 1.8 ( 0.07c 0.65 ( 0.04c
Se-yeast 1 8.1 ( 0.65a 8.5 ( 0.68a 0.25 ( 0.02a 1.5 ( 0.04a 0.62 ( 0.04a
Se-yeast 2 13.4 ( 0.98b 13.3 ( 0.96b 0.31 ( 0.02b 2.5 ( 0.11b 0.83 ( 0.06b
Se-yeast 3 15.9 ( 1.2c 20.4 ( 1.5c 0.41 ( 0.03c 3.8 ( 0.15c 0.94 ( 0.07c
a-c The values from the Se-garlic and Se-yeast groups are significantly different from each other (P < 0.05).
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probably because of the much lower sample number in
each category once the data were segregated. Nonethe-
less, it can be seen that, especially in the Se-garlic
group, the reduction in IDP number was more prevalent
in the larger-sized lesions. For example, there were only
7 lesions of >21 sections in the Se-garlic group as
compared to 16 in the Se-yeast group and 24 in the
control. The data suggest that (i) selenium chemopre-
vention is expressed at an early stage of carcinogenesis
and (ii) Se-garlic is more active than Se-yeast in
suppressing the clonal expansion of these early lesions.
The experiments evaluating the mammary cancer
prevention efficacies of Se-garlic and Se-yeast are
presented in Table 4. Both supplements were started
immediately after administration of either DMBA or
MNU and continued until termination of the study. The
data showed the change in tumor incidence and total
tumor number as the endpoint. On the basis of these
two parameters, our results indicated that Se-garlic was
more effective than Se-yeast in mammary cancer pro-
tection in both the DMBA and MNU models. The last
column of Table 4 shows the percent inhibition calcu-
lated from the tumor yield data; Se-garlic produced 66
and 70% inhibition in the DMBA and MNU experi-
ments, in contrast to only 34 and 31% inhibition for Se-
yeast.
DISCUSSION
In the present study, we found that Se-yeast was only
half as active as Se-garlic in our mammary cancer
chemoprevention studies, despite the fact that there was
a much higher total tissue selenium accumulation with
Se-yeast than with Se-garlic. Analytical speciation
studies showed that the bulk of the selenium in Se-garlic
and Se-yeast is in the form of ç-glutamyl-Se-methylse-
lenocysteine and selenomethionine, respectively. This
is the first time >90% of the chemical form of selenium
was identified and accounted for in a selenium-enriched
natural product. We will discuss the interdependence
of biology and chemistry in selenium chemoprevention
on the basis of the knowledge gained from our past
research.
We recently reported that a 1355 íg/g Se garlic
sample contains Se-methylselenocysteine as the major
form of selenium (Cai et al., 1995; Bird et al., 1997a),
in contrast to the present finding of ç-glutamyl-Se-
methylselenocysteine as the predominant compound in
a 296 íg/g Se garlic sample. Our additional studies
indicate that garlic samples containing <300 íg/g Se
all produce the ç-glutamyl derivative as a major storage
form for selenium. Both ç-glutamyl-Se-methylseleno-
cysteine and Se-methylselenocysteine were previously
identified in Astragalus bisulcatus (Nigan and McCon-
nell, 1969). Furthermore, ç-glutamyl-S-alk(en)ylcys-
teines are well-known sulfur storage compounds in
garlic (Virtanen, 1965; Koch and Lawson, 1996; Block,
1992). Interestingly, some earlier experiments by Ip and
Lisk (1995) demonstrated that the anticarcinogenic
effect of Se-garlic is unlikely to be affected by the degree
of selenium enrichment in the garlic sample. Further-
more, the highly enriched and moderately enriched Se-
garlic produced similar increases in tissue selenium
provided that the total intake of selenium was the same.
Given what we know now about the forms of selenium
in the 1355 and 296 íg/g Se garlic samples, it would be
reasonable to assume that ç-glutamyl-Se-methylsele-
nocysteine serves mainly as a carrier of Se-methylse-
lenocysteine. Following ingestion as a dietary constitu-
ent, ç-glutamyl-Se-methylselenocysteine (Figure 6) is
likely to be hydrolyzed by a transpeptidase in the
gastrointestinal tract, releasing Se-methylselenocys-
teine for absorption and systemic delivery to other
tissues. We plan to use pure ç-glutamyl-Se-methylse-
lenocysteine in our future experiments to examine the
pharmacokinetics of selenium accumulation and the
metabolic disposition of selenium from this molecule.
As shown in Figure 7, Se-methylselenocysteine is
metabolized in vivo by a â-lyase enzyme to methylse-
lenol (Foster et al., 1986; Ganther and Lawrence, 1997).
This enzyme is present in a number of tissues including
liver, kidney, mammary gland, and intestine (Ip et al.,
1999). On the basis of our past research experience, any
precursor that will generate methylselenol (or a related
monomethylated selenium intermediate) via a similar
reaction is more active than selenite or selenomethion-
ine in tumor inhibition (Ganther and Lawrence, 1997;
Ip and Ganther, 1992; Ip, 1998). Thus, the facile
endogenous production of monomethylated selenium is
a critical factor in selenium chemoprevention. This may
explain the superior activity of Se-garlic compared to
Table 3. Reduction in the Number of IDP Lesions by Se-Garlic or Se-Yeast in the Mammary Gland of Rats Given MNU
size distribution of IDP lesions
treatment
dietary selenium
(íg/g)
no. of
rats e10 sections 11-20 sections 21-30 sections 31-40 sections total no.
none 0.1 6 4 12 9 15 40
Se-garlic 3 6 5 5 3 4 17a
Se-yeast 3 6 5 8 6 10 29b
a P ) 0.005, compared to the Se-yeast group. b P ) 0.034, compared to the control group.
Table 4. Mammary Cancer Prevention by Se-Garlic or
Se-Yeast in the DMBA and MNU Models
model
treat-
ment
dietary
selenium
(íg/g)
tumor
incidence
total no.
of tumors
%
inhibitiona
DMBA none 0.1 26/30 74
Se-garlic 3 11/30b 25b 66
Se-yeast 3 19/30c 49c 34
MNU none 0.1 28/30 80
Se-garlic 3 10/30b 24b 70
Se-yeast 3 20/30c 55c 31
a Calculated based on total tumor yield data. b P < 0.05,
compared to the corresponding Se-yeast group. c P < 0.05, com-
pared to the corresponding control group.
Figure 6. Structures of ç-glutamyl-Se-methylselenocysteine,
Se-methylselenocysteine, and selenomethionine.
Se-yeast, because the latter delivers predominantly
selenomethionine.
The structures of Se-methylselenocysteine and sele-
nomethionine are very similar to each other (Figure 6).
Their respective molecular weights are 182 and 196, the
difference being accounted for by an additional meth-
ylene carbon in selenomethionine. Despite the similarity
in chemical structure, these two selenoamino acids are
metabolized very differently (Figure 7). Selenomethion-
ine is known to be incorporated nonspecifically into
tissue proteins in place of methionine during protein
synthesis, whereas this is not true for Se-methylsele-
nocysteine (Sunde, 1990). Total body burden of selenium
is therefore consistently higher in rats fed selenom-
ethionine compared to those fed other forms of selenium
(McAdam and Levander, 1987; Whanger and Butler,
1988; Ip and Hayes, 1989). Due to its compartmental-
ization into tissue proteins, selenomethionine is not as
readily available as Se-methylselenocysteine for further
metabolism. As noted above, the efficiency of a sele-
noamino acid in entering the methylation pathway of
selenium metabolism is important in selenium chemo-
prevention (Ganther and Lawrence, 1997; Ip and Gan-
ther, 1992; Ip, 1998). In contrast to the â-lyase-mediated
reaction converting Se-methylselenocysteine to meth-
ylselenol, selenomethionine is metabolized via the mul-
tistep transselenization mechanism to selenocysteine
analogous to the methionine transsulfuration mecha-
nism. Selenocysteine, in turn, is degraded to hydrogen
selenide before entering the methylation pathway (Ip
and Ganther, 1992). The slower rate of generating
monomethylated metabolite from selenomethionine may
also in part account for its lower anticarcinogenic
activity. A relationship between selenium source and
biological activity has also been described by Finley
(1998). He found that selenium from high-Se broccoli
was less effective in repleting peroxidase activity than
selenium from selenite, selenate, or selenomethionine.
Furthermore, more selenium from broccoli was excreted
in urine of rats than selenium from selenomethionine.
Because the appearance of IDP lesions precedes the
development of adenocarcinomas in the mammary
gland, their quantitative reduction by selenium treat-
ment suggests that the primary action of selenium is
to inhibit clonal expansion of the carcinogen-initiated
cells at an early stage of the disease process. It should
be pointed out that, in this study, the size of these
lesions is defined operationally by the number of serial
histologic sections containing the pathology. Our data
indicated that Se-garlic is more potent in suppressing
the growth of these premalignant lesions. This finding
implies that different selenium compounds may have
Speciation of selenoamino acids and organoselenium com-
pounds in selenium-enriched yeast using high-performance
liquid chromatography-inductively coupled plasma mass
spectrometry. J. Anal. Atom. Spectrom. 1997b, 12, 785-
788.
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1757.
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different efficacies in regulating the proliferation and/
or apoptosis of the early transformed cells. These 
research questions are presently under investigation.
The purpose of this paper is not to make recom-
mendation of one selenium-enriched product over an-
other for human use. The biological experiments re-
ported here were conducted in a particular animal 
model, which has its own share of limitations and 
confounders. The application of the present sophisti-
cated analytical instrumentation and methodology for 
selenium speciation has enabled a more informative and 
coherent approach to be followed than formerly was 
available to such investigations. The Clark (1996) trial 
has offered a glimmer of encouragement that significant 
cancer prevention can be achieved by selenium supple-
mentation. We hope to add to this research database 
by underscoring that chemistry and biology should go 
hand in hand in our continuing effort to develop new 
strategies for selenium intervention of cancer.
ABBREVIATIONS USED
HPLC, high-performance liquid chromatography; ICP, 
inductively coupled plasma; MS, mass spectrometry; 
ESI, electrospray; SIC, single ion chromatogram; IDP, 
intraductal proliferation lesion; MNU, methylnitrosourea; 
DMBA, dimethylbenz[a]anthracene.
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